Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study

This study is an examination of "high risk" young women, 15-24 years of age, who initiate first time use of vaginal ring, oral contraceptives, contraceptive path, or Depo-provera...

Date First Received: August 4, 2006

Last Updated: May 19, 2008

Verified by: University of California, San Francisco, May 2008

Clinical Trial Phase: N/A | Start Date: August 2005

Overall Status: Active, not recruiting

Estimated Enrollment: 1600

Brief Summary

Official Title: “Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study”

Condition Keyword(s):

This study is an examination of "high risk" young women, 15-24 years of age, who initiate first time use of vaginal ring, oral contraceptives, contraceptive path, or Depo-provera.

Study Type: Observational

Study Design: Ecologic or Community, Prospective

Study Primary Completion Date: September 2008

Detailed Clinical Trial Description

Approximately 1600 young women will be enrolled in a 12 month, observation study of their contraceptive use. They will complete surveys at baseline, 3, 6 and 12 months. They will also undergo pregnancy testing at baseline, 6 and 12 month visits. The study is examining such things are the relationship between partnerships, parental and peer influences, and contraceptive choice; Factors associated with long term continuation of contraceptive methods; Attributes of new hormonal contraceptive associated with user satisfaction and long-term continuation; And the extent to which high-risk women who use these methods are also condom users and determine the characteristics of these users.

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • 15-24 years old, English or spanish speaking, Starting ring, pill, patch, or Depo for first time, Sexually active, Single, Not pregnant, Living in Bay Area for next 12 months

Exclusion Criteria:

  • Past user of method, Married, Pregnant, Moving out of area, Not sexually active

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: 15 Years

Maximum Age for this Clinical Trial: 24 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers

Clinical Trial Sponsor Information

Lead Sponsor: University of California, San Francisco

Overall Clinical Trial Officials and Contacts

Tina R Raine, MD, MPH Principal Investigator University of California, San Francisco  

Additional Information

Information obtained from ClinicalTrials.gov on October 07, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00361400

Study ID Number: R01-HD045480-03

ClinicalTrials.gov Identifier: NCT00361400

Health Authority: United States: Institutional Review Board

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.